Cargando…
What is the impact of GOLD 2017 recommendations in primary care? – a descriptive study of patient classifications, treatment burden and costs
PURPOSE: The changes in grading of disease severity and treatment recommendations for patients with COPD in the 2017 GOLD strategy may present an opportunity for reducing treatment burden for the patients and costs to the health care system. The aim of this study was to assess the implications of th...
Autores principales: | Gayle, Alicia, Dickinson, Scott, Morris, Kevin, Poole, Chris, Mathioudakis, Alexander G, Vestbo, Jørgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207393/ https://www.ncbi.nlm.nih.gov/pubmed/30498338 http://dx.doi.org/10.2147/COPD.S173664 |
Ejemplares similares
-
What is the impact of GOLD 2017 recommendations in primary care? – a descriptive study of patient classifications, treatment burden and costs [Erratum]
Publicado: (2018) -
GOLD and the fixed ratio
por: Vestbo, Jørgen
Publicado: (2012) -
Was the implementation strategy of the ProACT trial adequately proactive?
por: Mathioudakis, Alexander G., et al.
Publicado: (2019) -
Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD)
por: Chalmers, James D., et al.
Publicado: (2018) -
Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study
por: Tzanakis, Nikolaos, et al.
Publicado: (2021)